Puriblood Medical Co., Ltd. (6847.TWO)

TWD 81.8

(-1.09%)

Operating Expenses Summary of Puriblood Medical Co., Ltd.

  • Puriblood Medical Co., Ltd.'s latest annual operating expenses in 2023 was 56.92 Million TWD , up 10.69% from previous year.
  • Puriblood Medical Co., Ltd.'s latest quarterly operating expenses in 2024 Q2 was 14.81 Million TWD , up 2.21% from previous quarter.
  • Puriblood Medical Co., Ltd. reported a annual operating expenses of 51.42 Million TWD in annual operating expenses 2022, up 25.45% from previous year.
  • Puriblood Medical Co., Ltd. reported a annual operating expenses of 40.99 Million TWD in annual operating expenses 2021, up 48.14% from previous year.
  • Puriblood Medical Co., Ltd. reported a quarterly operating expenses of 14.81 Million TWD for 2024 Q2, up 2.21% from previous quarter.
  • Puriblood Medical Co., Ltd. reported a quarterly operating expenses of 14.37 Million TWD for 2023 Q2, down 0.0% from previous quarter.

Annual Operating Expenses Chart of Puriblood Medical Co., Ltd. (2023 - 2019)

Historical Annual Operating Expenses of Puriblood Medical Co., Ltd. (2023 - 2019)

Year Operating Expenses Operating Expenses Growth
2023 56.92 Million TWD 10.69%
2022 51.42 Million TWD 25.45%
2021 40.99 Million TWD 48.14%
2020 27.67 Million TWD 229.33%
2019 -21.39 Million TWD 0.0%

Peer Operating Expenses Comparison of Puriblood Medical Co., Ltd.

Name Operating Expenses Operating Expenses Difference
BIONET Corp. 553.58 Million TWD 89.717%
DIVA Laboratories, Ltd. 158.62 Million TWD 64.112%
Genetics Generation Advancement Corp. 218.25 Million TWD 73.918%
Welgene Biotech Co.,Ltd. 123.97 Million TWD 54.083%
TFBS Bioscience Inc. 77.82 Million TWD 26.858%